The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner
Overview
Authors
Affiliations
Significance: Sensitivity to the tumoricidal effect of ZIKV on high-risk neuroblastoma tumors is dependent on CD24 expression, offering a prognostic marker for this oncolytic therapy in an extensive array of CD24-expressing cancers.
Neuroblastoma-A Review of Combination Immunotherapy.
Pieniazek B, Cencelewicz K, Bzdziuch P, Mlynarczyk L, Lejman M, Zawitkowska J Int J Mol Sci. 2024; 25(14).
PMID: 39062971 PMC: 11276848. DOI: 10.3390/ijms25147730.
Calderon-Pelaez M, Maradei Anaya S, Bedoya-Rodriguez I, Gonzalez-Ipuz K, Vera-Palacios D, Buitrago I Viruses. 2024; 16(4).
PMID: 38675903 PMC: 11055012. DOI: 10.3390/v16040561.